NextCell Pharma AB (STO:NXTCL)

NextCell Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr 10, 2026	Dec 31, 2025	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022
Market Capitalization	148	81	130	93	124	218
Market Cap Growth	-33.96%	-37.52%	40.40%	-25.00%	-43.31%	-56.21%
Enterprise Value	122	43	114	72	61	111
Last Close Price	1.33	0.73	1.17	1.27	3.60	6.35
PS Ratio	15.02	8.28	11.78	8.23	8.87	35.05
PB Ratio	2.92	1.61	1.96	1.37	1.63	1.89
P/TBV Ratio	2.92	1.61	1.96	1.37	1.63	1.89
EV/Sales Ratio	12.37	4.34	10.27	6.39	4.34	17.86
Net Debt / Equity Ratio	-0.51	-0.51	-0.58	-0.69	-0.66	-0.84
Net Debt / EBITDA Ratio	0.70	0.70	1.16	1.11	1.23	2.81
Net Debt / FCF Ratio	0.56	0.56	0.90	1.24	1.04	2.37
Asset Turnover	-	-	0.14	0.13	0.13	0.04
Inventory Turnover	-	-	17.24	22.79	14.12	-
Quick Ratio	3.92	3.92	8.05	5.06	5.32	14.40
Current Ratio	5.16	5.16	10.02	6.15	6.67	15.40
Return on Equity (ROE)	-	-	-52.46%	-58.55%	-41.63%	-26.02%
Return on Assets (ROA)	-	-	-28.39%	-31.72%	-24.01%	-15.62%
Return on Capital Employed (ROCE)	-70.60%	-70.60%	-50.30%	-60.50%	-52.10%	-29.80%
Earnings Yield	-26.26%	-47.64%	-26.96%	-45.20%	-32.17%	-15.83%
FCF Yield	-31.53%	-57.20%	-33.03%	-40.79%	-38.72%	-18.74%
Buyback Yield / Dilution	-	-	-87.22%	-18.72%	-	-13.05%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.